TY  - JOUR
AU  - Lewinska, Monika
AU  - Santos-Laso, Alvaro
AU  - Arretxe, Enara
AU  - Alonso, Cristina
AU  - Zhuravleva, Ekaterina
AU  - Jimenez-Agüero, Raul
AU  - Eizaguirre, Emma
AU  - Pareja, María Jesús
AU  - Romero-Gómez, Manuel
AU  - Arrese, Marco
AU  - Suppli, Malte P
AU  - Knop, Filip K
AU  - Oversoe, Stine Karlsen
AU  - Villadsen, Gerda Elisabeth
AU  - Decaens, Thomas
AU  - Carrilho, Flair Jose
AU  - de Oliveira, Claudia Pms
AU  - Sangro, Bruno
AU  - Macias, Rocio I R
AU  - Banales, Jesus M
AU  - Andersen, Jesper B
PY  - 2021
DO  - 10.1016/j.ebiom.2021.103661
UR  - https://hdl.handle.net/10668/26529
T2  - EBioMedicine
AB  - Non-alcoholic fatty liver disease (NAFLD) is affecting more people globally. Indeed, NAFLD is a spectrum of metabolic dysfunctions that can progress to hepatocellular carcinoma (NAFLD-HCC). This development can occur in a non-cirrhotic liver and thus,...
LA  - en
KW  - HCC
KW  - NAFLD
KW  - biomarker discovery
KW  - lipidomics
KW  - metabolomics
KW  - Biomarkers
KW  - Carcinoma, Hepatocellular
KW  - Case-Control Studies
KW  - Gene Expression Profiling
KW  - Humans
KW  - Lipidomics
KW  - Lipids
KW  - Liver Neoplasms
KW  - Non-alcoholic Fatty Liver Disease
KW  - Prognosis
KW  - ROC Curve
KW  - Reproducibility of Results
KW  - Workflow
TI  - The altered serum lipidome and its diagnostic potential for Non-Alcoholic Fatty Liver (NAFL)-associated hepatocellular carcinoma.
TY  - research article
VL  - 73
ER  -